由美国食品与药品管理局批准治疗转移克隆癌的贝伐单抗，是血管内皮生长因子的单克隆抗体。
Bevacizumab, a monoclonal antibody targeting vascular endothelial growth factor, is approved by the US Food and Drug Administration for metastatic colon cancer.
目的：检测肝细胞癌患者血清血管内皮生长因子与基质金属蛋白酶- 9含量并分析与临床分期的相关性。
Objective to detect the concentration of serum vascular endothelial growth factor and matrix metalloproteinase-9 in hepatocellular carcinoma and analyze their relation with the clinical stages.
目的：研究血管内皮生长因子在宫颈癌组织中的表达特点及其意义。
Objective: to investigate the expression and role of vascular endothelial growth factor in cervical carcinoma tissue.
应用推荐